Csilla Ambrus-Temesszentandrasi
Charles River Laboratories Hungary
Budapest, BU 1117, Hungary
Budapest, BU 1117, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Quantifying Transporter Activity: An Absolute Scaling Approach Using Digoxin.
Journal: Molecular pharmaceutics
Published: June 15, 2026
Modulation of Multispecific Transporters by Uncaria tomentosa Extract and Its Major Phytoconstituents.
Journal: Pharmaceutics
Published: September 10, 2024
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.
Journal: Pharmaceutics
Published: April 30, 2024
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC).
Journal: Archives of toxicology
Published: September 28, 2023
Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters.
Journal: International journal of molecular sciences
Published: June 04, 2023
A Unique In Vitro Assay to Investigate ABCB4 Transport Function.
Journal: International journal of molecular sciences
Published: January 13, 2023
The Inhibitor Preincubation Effect Is Universal to SLC Transporter Assays and Is Only Partially Eliminated in the Presence of Extracellular Protein.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: October 30, 2022
Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk.
Journal: Journal of pharmaceutical sciences
Published: October 16, 2022
Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
Journal: Cells
Published: September 16, 2022
Characterization of new, efficient Mycobacterium tuberculosis topoisomerase-I inhibitors and their interaction with human ABC multidrug transporters.
Journal: PloS one
Published: February 16, 2018
Baicalin is a substrate of OATP2B1 and OATP1B3.
Journal: Phytotherapy research : PTR
Published: September 19, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026